The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study.
about
Oral nonsteroidal anti-inflammatory drugs for neuropathic painBuprenorphine for neuropathic pain in adultsOxycodone for neuropathic pain in adultsParacetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adultsHydromorphone for neuropathic pain in adultsCannabinoids for chronic neuropathic painPharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisMethadone for neuropathic pain in adultsNew Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain.The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendationsThe International Spinal Cord Injury Pain Extended Data Set (Version 1.0).Topical capsaicin (high concentration) for chronic neuropathic pain in adults.Gabapentin for chronic neuropathic pain in adults.Functional and structural assessment of patients with and without persistent pain after thoracotomy.Usefulness of laser-evoked potentials and quantitative sensory testing in the diagnosis of neuropathic spinal cord injury pain: a multiple case study.Ipsilateral and contralateral sensory changes in healthy subjects after experimentally induced concomitant sensitization and hypoesthesia.Neuropathic Pain and Spinal Cord Injury: Phenotypes and Pharmacological Management.Drug therapy for chronic idiopathic axonal polyneuropathy.New Directions in the Treatment of Chronic Pain: National Pain Strategy Will Guide Prevention, Management, and Research.Somatosensory abnormalities in Chinese patients with painful temporomandibular disorders.The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy.Sensory phenotype and risk factors for painful diabetic neuropathy: a cross sectional observational study.A Systematic Review of Treatment of Painful Diabetic Neuropathy by Pain Phenotype versus Treatment Based on Medical Comorbidities.Hopes for the Future of Pain Control.Tramadol for neuropathic pain in adults.Impact of etiology and duration of pain on pharmacological treatment effects in painful polyneuropathy.Morphine for chronic neuropathic pain in adults.Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.Experimental pain phenotyping in community-dwelling individuals with knee osteoarthritis.Nervous System Sensitization as a Predictor of Outcome in the Treatment of Peripheral Musculoskeletal Conditions: A Systematic Review.The Pharmacological Therapy of Chronic Neuropathic PainExploring pain pathophysiology in patients.Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults.[Botulinum toxin A injections in neuropathic pain : A post-hoc subgroup analysis of patients with peripheral nerve injury].Changes of the Sensory Abnormalities and Cortical Excitability in Patients with Complex Regional Pain Syndrome of the Upper Extremity After 6 Months of Multimodal Treatment.Calcium channel modulation as a target in chronic pain control.Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain.Vendor-derived differences in injury-induced pain phenotype and pharmacology of Sprague-Dawley rats: Does it matter?Neuropathic orofacial pain: Facts and fiction.
P2860
Q24186621-E3F3DEB8-1E49-4A5C-8F97-2266C55632C7Q24186924-D9BD77F3-8CFB-4CAD-AF80-A5746BD5F821Q26470985-F038B395-9C7F-43AF-BF44-44903134C770Q26471756-0E2AECE6-4E93-40EE-87E1-ED2A7ED407ECQ26471921-FAF73E36-4851-4E03-86DE-C48A4C413D65Q26472068-30795A5C-B5A2-4E3F-A8F1-0C466BDD6F52Q28085455-5A9EEFD2-272B-4920-9555-7977B52942B9Q29994484-43C5879B-C9DF-4F77-ACA1-618435390C17Q30235132-A3D6DC4E-7D01-46C5-8949-50F3C6AE257EQ30235485-229401AE-D7CF-48C2-A950-F874BE99E27EQ30491945-0A5377EF-BB25-45B6-BCB2-7E6ADAE09410Q31074086-71C1379A-7E53-4B58-A363-66A7D1F44C86Q34549233-3CB27593-FED8-424E-86FB-F067693572C6Q34557703-1B77B2BF-A4FF-4B1F-A72F-DFD97643992DQ36087897-E596987D-4A4A-4353-B214-8A36FBFC3B60Q36258457-2CF5EB0D-CDE3-42C1-B86F-6C612C97C19AQ36320939-A7D64C10-D692-4DAC-B433-1DFACC0AFAD6Q36357469-9B320616-15DD-4D09-8331-18D3909C58E4Q36410068-48FED93B-C063-497C-840F-F1CE9AE21AEDQ36557004-814C7DA9-A3FF-4BAB-B94B-A70EF1F74D39Q36792395-D610336F-C9A4-4AE0-8DA0-ECAC80E34AC5Q36807236-5DBFF0D5-B440-4C99-A575-F0EE6FAE606BQ38599813-FCE41E4D-2C1B-4585-8254-D8645B973C58Q38662818-450C46BF-5683-4AF0-99D3-8736FF4AAFBAQ38679986-41266E6A-2C2F-4CD9-BDD3-D352F52BD030Q38724793-D896BE90-4F52-4512-84D7-BAEF74208737Q38756875-2174131C-8C23-435B-B53A-852EA4C7DC86Q38771530-9AF7824F-53E7-499E-9842-56E556BB2726Q38827493-03DCE473-BAB8-44D7-9C71-249DE834AD76Q38848882-727CCD28-065C-444E-93B4-137667FB1617Q38931067-BAA379FA-1697-4D17-ACAD-006DA35DE8B0Q38970946-EB29B07D-288E-4342-B154-8B25CBCDBF61Q38998012-085E732C-C67E-49F8-B464-7C02F007A9ECQ39058716-ED996E23-8790-4400-BAB2-CEA03E8ADBF2Q39153537-60D90289-A6B4-49BC-A522-76EE4EBF0B76Q39169770-1CEC80AE-6606-4A62-ABE9-7BBA30E71B1DQ39188300-A48E9249-B5E3-45B9-9817-26E9CE7DA14AQ39191235-932EE84C-3126-4BE9-BCBF-7981EADD26BEQ39224301-172C9DFF-9FA1-43AE-AB6F-983590FEAD90Q39238262-D949BF37-6B71-4391-ABE2-DE25ED5533B9
P2860
The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The effect of oxcarbazepine in ...... ed phenotype-stratified study.
@en
The effect of oxcarbazepine in ...... ed phenotype-stratified study.
@nl
type
label
The effect of oxcarbazepine in ...... ed phenotype-stratified study.
@en
The effect of oxcarbazepine in ...... ed phenotype-stratified study.
@nl
prefLabel
The effect of oxcarbazepine in ...... ed phenotype-stratified study.
@en
The effect of oxcarbazepine in ...... ed phenotype-stratified study.
@nl
P2093
P50
P1433
P1476
The effect of oxcarbazepine in ...... ed phenotype-stratified study.
@en
P2093
Christoph Maier
Dyveke T Demant
Karen Lund
Märtha Segerdahl
P304
P356
10.1016/J.PAIN.2014.08.014
P407
P577
2014-08-17T00:00:00Z